Clinical Trials
3
Active:0
Completed:0
Trial Phases
2 Phases
Phase 3:1
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (66.7%)Phase 3
1 (33.3%)Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen in Acute Myeloid Leukemia: Study Protocol for a Randomized Controlled Trial
- First Posted Date
- 2022-05-19
- Last Posted Date
- 2022-05-19
- Lead Sponsor
- Huihan Wang
- Target Recruit Count
- 130
- Registration Number
- NCT05382390
- Locations
- 🇨🇳
ShengJing Hospital of China Medical University, Shenyang, Liaoning, China
Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen for Elderly Patients With Acute Myeloid Leukemia: A Phase II Single-Arm Multicenter Study
- First Posted Date
- 2022-02-28
- Last Posted Date
- 2022-02-28
- Lead Sponsor
- Huihan Wang
- Target Recruit Count
- 130
- Registration Number
- NCT05258799
- Locations
- 🇨🇳
ShengJing Hospital of China Medical University, Shenyang, Liaoning, China
D-CTAG in the Treatment of Newly Diagnosed Acute Myeloid Leukemia in Elderly Patients
- First Posted Date
- 2019-11-19
- Last Posted Date
- 2019-11-19
- Lead Sponsor
- Huihan Wang
- Target Recruit Count
- 20
- Registration Number
- NCT04168138
- Locations
- 🇨🇳
ShengJing Hospital of China Medical University, Shenyang, Liaoning, China
News
No news found